NCT02459119 2020-08-06
Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)
University of Alabama at Birmingham
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) × regorafenib × Clear all